Sheraz Gul

2.1k total citations
90 papers, 1.2k citations indexed

About

Sheraz Gul is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Sheraz Gul has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 17 papers in Organic Chemistry and 16 papers in Epidemiology. Recurrent topics in Sheraz Gul's work include Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (12 papers) and Computational Drug Discovery Methods (10 papers). Sheraz Gul is often cited by papers focused on Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (12 papers) and Computational Drug Discovery Methods (10 papers). Sheraz Gul collaborates with scholars based in Germany, United Kingdom and Italy. Sheraz Gul's co-authors include Kamyar Hadian, K Brocklehurst, Philip Gribbon, E.D. Lowe, Nick R. Brown, Ivo Tews, S.J. Gamblin, L.N. Johnson, M.E.M. Noble and Chandra Verma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Stroke.

In The Last Decade

Sheraz Gul

83 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheraz Gul Germany 20 736 217 215 116 115 90 1.2k
Ganesha Rai United States 26 1.3k 1.8× 311 1.4× 175 0.8× 163 1.4× 153 1.3× 90 2.2k
Kevin P. Madauss United States 19 783 1.1× 162 0.7× 454 2.1× 161 1.4× 98 0.9× 28 1.6k
Jaeki Min United States 27 1.2k 1.6× 451 2.1× 390 1.8× 140 1.2× 111 1.0× 55 2.0k
William Seibel United States 22 943 1.3× 438 2.0× 176 0.8× 80 0.7× 85 0.7× 66 1.6k
Jonathan A. Lee United States 15 754 1.0× 133 0.6× 130 0.6× 280 2.4× 53 0.5× 24 1.3k
Scott J. Novick United States 22 1.3k 1.8× 93 0.4× 242 1.1× 99 0.9× 79 0.7× 41 1.9k
Aude Echalier United Kingdom 21 729 1.0× 245 1.1× 377 1.8× 124 1.1× 58 0.5× 29 1.3k
David Fox United States 24 1.1k 1.6× 564 2.6× 237 1.1× 70 0.6× 129 1.1× 39 2.0k
P. Loppnau Canada 28 2.1k 2.9× 122 0.6× 361 1.7× 83 0.7× 192 1.7× 54 2.7k
Salvatore Di Maro Italy 25 755 1.0× 227 1.0× 260 1.2× 83 0.7× 72 0.6× 63 1.3k

Countries citing papers authored by Sheraz Gul

Since Specialization
Citations

This map shows the geographic impact of Sheraz Gul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheraz Gul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheraz Gul more than expected).

Fields of papers citing papers by Sheraz Gul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheraz Gul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheraz Gul. The network helps show where Sheraz Gul may publish in the future.

Co-authorship network of co-authors of Sheraz Gul

This figure shows the co-authorship network connecting the top 25 collaborators of Sheraz Gul. A scholar is included among the top collaborators of Sheraz Gul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheraz Gul. Sheraz Gul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weng, Jialei, Feng Ju, Ningbo Fan, et al.. (2025). Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers. Journal of Experimental & Clinical Cancer Research. 44(1). 314–314.
4.
Maeda, Mitsuyo, Yosky Kataoka, Takayuki Nakagomi, et al.. (2024). Direct Water-Soluble Molecules Transfer from Transplanted Bone Marrow Mononuclear Cell to Hippocampal Neural Stem Cells. Stem Cells and Development. 33(17-18). 505–515. 2 indexed citations
5.
Khalid, Asaad, et al.. (2024). In-vitro Cytotoxicity Investigations for Phytoconstituents of Saudi Medicinal Plants With Putative Ocular Effects. Integrative Cancer Therapies. 23. 1573571785–1573571785. 3 indexed citations
6.
Linciano, Pasquale, Cecilia Pozzi, Giacomo Landi, et al.. (2023). The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents. European Journal of Medicinal Chemistry. 264. 115946–115946. 3 indexed citations
7.
Siegerist, Florian, et al.. (2023). A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS—Like Zebrafish Model. Journal of the American Society of Nephrology. 34(12). 1977–1990. 6 indexed citations
8.
Taguchi, Akihiko, Akiko Takeda, Takayuki Okamoto, et al.. (2023). Activation of neurogenesis in the hippocampus is a novel therapeutic target for Alzheimer's disease. SHILAP Revista de lepidopterología. 1(2). 139–142. 5 indexed citations
9.
Khalid, Asaad, et al.. (2023). The use of medicinal plants in common ophthalmic disorders: A systematic review with meta-analysis. Heliyon. 9(4). e15340–e15340. 2 indexed citations
10.
Sestito, Simona, Massimiliano Runfola, Francesca Gado, et al.. (2021). Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile. European Journal of Medicinal Chemistry. 226. 113895–113895. 8 indexed citations
11.
Salado, Irene G., Abhimanyu K. Singh, Marco Siderius, et al.. (2020). Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds. Journal of Medicinal Chemistry. 63(7). 3485–3507. 6 indexed citations
12.
Robinson, William J., George W. Weaver, Randolph Arroo, et al.. (2020). The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines. European Journal of Medicinal Chemistry. 209. 112871–112871. 5 indexed citations
13.
Uliassi, Elisa, Giulia Fiorani, R. Luise Krauth‐Siegel, et al.. (2017). Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase ( Tb GAPDH) and Trypanosoma cruzi trypanothione reductase ( Tc TR) and display trypanocidal activity. European Journal of Medicinal Chemistry. 141. 138–148. 25 indexed citations
14.
Pisa, F. Di, Giacomo Landi, Cecilia Pozzi, et al.. (2017). Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. Molecules. 22(3). 426–426. 39 indexed citations
15.
Spry, Christina, et al.. (2017). Structure-activity analysis of CJ-15,801 analogues that interact with Plasmodium falciparum pantothenate kinase and inhibit parasite proliferation. European Journal of Medicinal Chemistry. 143. 1139–1147. 13 indexed citations
16.
Thompson, Maria, et al.. (2013). The evolution of the Contract Research Organisation and the future of the pharmaceutical industry. 18(1). 60–62. 3 indexed citations
17.
18.
Hassan, Namir J., Sheraz Gul, Fiona Flett, et al.. (2008). Development of an insect-cell-based assay for detection of kinase inhibition using NF-κB-inducing kinase as a paradigm. Biochemical Journal. 419(1). 65–73. 6 indexed citations
20.
Resmini, Marina, Sheraz Gul, Sanjiv Sonkaria, Gerard Gallacher, & K Brocklehurst. (1998). Determination of the catalytic site content of a polyclonal catalytic antibody preparation. Biochemical Society Transactions. 26(2). S170–S170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026